A Comparison of XELOX Regimen & EOX Regimen as Neoadjuvant Chemotherapy

Updated 06/21/2024

Status Completed

Clinical Trial Summary

This study is designed to assess what is the better neoadjuvant chemotherapy regimen for patients with initially unresectable locally advanced gastric cancer.

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02192983
Study type	Observational [Patient Registry]
Source	Shanghai Zhongshan Hospital
Contact
Status	Completed
Phase	N/A
Start date	November 2008
Completion date	May 2015

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT05545436` - Carrelizumab (PD-1) Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer	Phase 2
	Not yet recruiting	`NCT05524974` - Clinical Study of Camrelizumab, Apatinib Mesylate and Nab-paclitaxel Combined With Oxplatin and S-1 in the Neoadjuvant Treatment of Locally Advanced Gastric Cancer With Different Genotypes	Phase 2
	Active, not recruiting	`NCT03192735` - Apatinib Combined With SOX Neoadjuvant Therapy for Locally Advanced Gastric Cancer	Phase 2
	Recruiting	`NCT03961373` - Standard Versus Super-extended Lymphadenectomy After Neo-adjuvant Chemotherapy for Gastric Cancer	Phase 3
	Not yet recruiting	`NCT05610332` - Clinical Efficacy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer With Different Immunotypes	Phase 3
	Recruiting	`NCT02855788` - Metronomic Chemotherapy in Advanced Gastric Cancer	Phase 2
	Not yet recruiting	`NCT02365896` - Comparison of Short Term Outcomes Between Totally Laparoscopic and Laparoscopy-Assisted Distal Gastrectomy With Billroth-II Reconstruction and D2 Lymphadenectomy for Locally Advanced Gastric Cancer	N/A
	Not yet recruiting	`NCT06459921` - Efficacy and Safety of Neoadjuvant Sintilimab Plus FLOT Versus Sintilimab Plus SOX Phase II Clinical Trial for Patients With Locally Advanced Gastric Cancer	Phase 2
	Recruiting	`NCT05141747` - A Study of MRG002 in the Treatment of HER2-positive/HER2-low Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer.	Phase 2
	Active, not recruiting	`NCT06277453` - Effect of Adjuvant Chemotherapy Cycles on Patients With Node-negative Gastric Cancer Following Neoadjuvant Chemotherapy
	Recruiting	`NCT05528367` - Tirelizumab in Combination With Chemoradiation in Patients With Unresectable Gastric Cancer or Gastroesophageal Junction Adenocarcinoma	Phase 2
	Recruiting	`NCT04792515` - Camrelizumab Combined With SOX and/or Apatinib for Locally Advanced Gastric Cancer	Phase 2
	Active, not recruiting	`NCT06235164` - The Safety and Efficacy of Neoadjuvant Immunochemotherapy Followed by Laparoscopic Gastrectomy for Gastric Cancer
	Recruiting	`NCT03322969` - Receiving Modified Chemotherapy Followed With Radical Resection After Neoadjuvant Chemotherapy	Phase 2
	Recruiting	`NCT02302794` - A Multicenter Clinical Trial on Laparoscopic Gastric Cancer Surgery Compared With Open Surgery	Phase 3